Enzymes and proteins atlas
A searchable table of 177 human enzymes, transporters, regulators and plasma proteins that digest, transform, carry or respond to dietary compounds. Each row is built from the protein's reviewed UniProt record and Human Protein Atlas tissue RNA data, and links to both.
Human Protein Atlas 25.1, tissue section and tissue RNA download, retrieved October 29, 2026; UniProtKB release 2026_03.
Status. Education, not medical advice. Rows restate public database records; they do not describe any EUTECNIQ product, study or laboratory result. EUTECNIQ is in formation and has none.
Related: ADME, PK and PBPK · Proteins, peptides and collagen · Compound atlas · Supplement interactions
The atlas covers 177 of about 20,000 human protein-coding genes
Counts of human protein-coding genes differ by database and release. The Human Protein Atlas (HPA) 25.1 classifies “all putative 20162 protein coding genes” by tissue RNA. UniProt's human reference proteome (UP000005640) reports a gene count of 20,652, and its reviewed Swiss-Prot section held 20,431 human entries in release 2026_03.
This atlas takes a defined subset in ten systems: digestive enzymes, phase I and phase II drug-metabolizing enzymes, transporters, the nuclear receptors and transcription factors that switch those genes on, the enzymes measured in liver tests, neurotransmitter enzymes and transporters, major plasma proteins, antioxidant and metabolic enzymes, and vitamin-related enzymes and carriers. The selection is editorial; it is not a ranking of importance.
The basics of first-pass metabolism, CYP enzymes, pharmacokinetic equations and PBPK models are on the ADME, PK and PBPK page. This page goes one level deeper: one row per protein, with its record.
| HPA category | HPA definition | Atlas proteins |
|---|---|---|
| Tissue enriched | “At least four-fold higher mRNA level in a particular tissue/cell type compared to any other tissues/cell types” | 68 |
| Group enriched | “At least four-fold higher average mRNA level in a group of 2-5 tissues or grouped cell types compared to any other tissues/cell types” | 30 |
| Tissue enhanced | “At least four-fold higher mRNA level in a particular tissue/cell type compared to the average level in all other tissues/cell types” | 57 |
| Low tissue specificity | None of the elevated categories | 20 |
| Not detected | No tissue reached detection | 1 (TPH2) |
| Not in the HPA search | Gene symbol not returned by the HPA download API | 1 (GSTT1) |
Human Protein Atlas 25.1: tissue section (“all putative 20162 protein coding genes”) and tissue-specific proteome page (category definitions, quoted), retrieved October 29, 2026. UniProt proteome UP000005640 and UniProtKB/Swiss-Prot release 2026_03 (September 2, 2026), retrieved October 29, 2026. Counts in the last column computed on this page from the HPA download.
Show data: atlas proteins by system and organ of main expression
| System | Liver and gallbladder | Esophagus, stomach and intestine | Pancreas | Salivary gland | Kidney and bladder | Brain, spinal cord and retina | Blood-forming and lymphoid tissue | Muscle and heart | Endocrine glands | Reproductive tissue and placenta | Many tissues (low tissue specificity) | Not detected or not in HPA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Digestive enzymes | 9 | 10 | 1 | 1 | ||||||||
| Phase I metabolism | 21 | 2 | 1 | |||||||||
| Phase II conjugation | 13 | 3 | 1 | 1 | 2 | 1 | ||||||
| Transporters | 8 | 8 | 4 | 2 | 2 | 3 | 1 | 3 | ||||
| Regulators of enzyme expression | 2 | 2 | ||||||||||
| Liver-test enzymes | 2 | 1 | 1 | 1 | 2 | 1 | 1 | |||||
| Neurotransmitter enzymes and transporters | 2 | 1 | 6 | 1 | 4 | 1 | 2 | 1 | ||||
| Plasma proteins | 14 | 1 | 1 | |||||||||
| Antioxidant and metabolic enzymes | 4 | 1 | 1 | 4 | 2 | 6 | ||||||
| Vitamin-related enzymes and carriers | 6 | 2 | 2 | 1 | 4 | |||||||
| All 177 | 70 | 28 | 12 | 1 | 10 | 10 | 6 | 5 | 10 | 3 | 20 | 2 |
Organ of main expression: the HPA tissue with the highest specific nTPM for enriched and enhanced genes, grouped into organs on this page; “many tissues” for genes of low tissue specificity.
CYP and UGT enzymes are liver-heavy, the gut wall shares CYP3A4, and OAT1, OAT3 and OCT2 are highest in kidney
CYP3A4 RNA in small intestine (754 nTPM) is about a fifth of the liver level (3,367 nTPM), while P-gp (ABCB1) and BCRP (ABCG2) RNA is higher in small intestine than in liver.
Show data: nTPM values for the 25 genes
| Gene | Liver | Duodenum | Small intestine | Colon | Stomach | Kidney | Lung | Cerebral cortex | Placenta | HPA category |
|---|---|---|---|---|---|---|---|---|---|---|
| CYP1A2 | 478 | 0.1 | 0.2 | 0.1 | 0.2 | 0.2 | 0.4 | 0.2 | 0.7 | Tissue enriched |
| CYP2A6 | 1,508 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.3 | 0.0 | 0.0 | Tissue enriched |
| CYP2B6 | 550 | 7.4 | 7.1 | 4.7 | 0.5 | 14 | 5.6 | 0.1 | 0.0 | Tissue enriched |
| CYP2C8 | 2,014 | 0.1 | 1.0 | 0.4 | 5.5 | 1.3 | 0.4 | 1.7 | 0.1 | Tissue enriched |
| CYP2C9 | 1,608 | 83 | 44 | 1.3 | 16 | 2.1 | 0.1 | 0.0 | 0.0 | Tissue enriched |
| CYP2C19 | 178 | 30 | 13 | 0.3 | 2.8 | 0.0 | 0.0 | 0.0 | 0.0 | Tissue enriched |
| CYP2D6 | 386 | 3.5 | 15 | 0.5 | 0.1 | 0.3 | 0.1 | 0.2 | 0.0 | Tissue enriched |
| CYP2E1 | 9,697 | 1.3 | 2.0 | 4.8 | 6.4 | 8.5 | 2.4 | 8.6 | 1.3 | Tissue enriched |
| CYP3A4 | 3,367 | 713 | 754 | 2.9 | 1.1 | 4.2 | 0.0 | 0.0 | 0.0 | Tissue enriched |
| CYP3A5 | 319 | 120 | 167 | 27 | 82 | 12 | 9.5 | 0.9 | 0.4 | Tissue enhanced |
| UGT1A1 | 345 | 189 | 75 | 2.8 | 2.3 | 3.7 | 0.2 | 0.2 | 0.1 | Group enriched |
| UGT1A4 | 368 | 5.4 | 1.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | Tissue enriched |
| UGT1A9 | 184 | 0.1 | 0.3 | 0.8 | 0.2 | 428 | 0.0 | 0.2 | 0.0 | Group enriched |
| UGT2B7 | 1,507 | 65 | 63 | 3.5 | 0.8 | 1,213 | 0.3 | 0.7 | 0.1 | Group enriched |
| ABCB1 (P-gp) | 26 | 25 | 67 | 16 | 2.0 | 32 | 6.0 | 8.7 | 2.2 | Tissue enhanced |
| ABCG2 (BCRP) | 34 | 45 | 83 | 15 | 1.8 | 3.3 | 4.8 | 14 | 11 | Tissue enhanced |
| ABCC2 (MRP2) | 114 | 37 | 38 | 0.5 | 0.6 | 17 | 0.5 | 0.1 | 0.4 | Tissue enhanced |
| SLCO1B1 (OATP1B1) | 502 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | Tissue enriched |
| SLCO1B3 (OATP1B3) | 248 | 0.1 | 0.1 | 0.3 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | Tissue enriched |
| SLC22A1 (OCT1) | 596 | 0.0 | 0.2 | 0.2 | 0.3 | 0.8 | 0.4 | 0.1 | 0.0 | Tissue enriched |
| SLC22A2 (OCT2) | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 144 | 0.0 | 0.4 | 0.5 | Tissue enriched |
| SLC22A6 (OAT1) | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 184 | 0.0 | 2.2 | 0.0 | Tissue enriched |
| SLC22A8 (OAT3) | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | 313 | 0.0 | 1.5 | 0.0 | Group enriched |
| SLC47A1 (MATE1) | 97 | 1.3 | 1.2 | 2.0 | 1.1 | 94 | 6.6 | 4.4 | 0.4 | Tissue enhanced |
| SLC47A2 (MATE2-K) | 0.0 | 0.0 | 0.3 | 0.0 | 0.0 | 61 | 0.0 | 0.2 | 0.0 | Group enriched |
Values as served by the HPA download API (columns “Tissue RNA - <tissue> [nTPM]”), rounded on this page; the heat map prints “<1” for values below 1 nTPM.
Explanation, details and sources
nTPM is normalized transcripts per million: a measure of how much messenger RNA for a gene a tissue sample contains, scaled so that samples can be compared. It does not measure protein, and protein amount does not measure activity.
SLCO1B1, SLCO1B3 and SLC22A1 (OATP1B1, OATP1B3, OCT1) RNA is “tissue enriched” in liver, and SLC22A2 and SLC22A6 (OCT2, OAT1) RNA in kidney. SLC22A8 and SLC47A2 (OAT3, MATE2-K) are “group enriched” in kidney and choroid plexus, a brain tissue not in the heat map; MATE2-K RNA is higher in choroid plexus (123 nTPM) than in kidney (61 nTPM). UGT1A9 RNA is higher in kidney (428 nTPM) than in liver (184 nTPM), and UGT2B7 is nearly as high in kidney (1,213) as in liver (1,507).
The FDA's clinical interaction table lists seven CYPs (1A2, 2B6, 2C8, 2C9, 2C19, 2D6 and 3A) and nine transporters (P-gp, BCRP, OATP1B1, OATP1B3, OAT1, OAT3, MATE1, MATE2-K and OCT2) with example substrates, inhibitors and inducers, and includes St John's wort, curcumin and diosmin among the substances listed. Those links are in the atlas rows below.
Human Protein Atlas 25.1; UniProtKB 2026_03 FUNCTION comments; U.S. FDA, Examples of Drugs that Interact with CYP Enzymes and Transporter Systems, content current as of May 29, 2026. First-pass physiology: First pass and the enzymes.
Liver tests measure enzymes that heart, muscle, gut and placenta also make
GPT (ALT1) RNA is highest in liver, while both AST genes (GOT1, GOT2) are as high or higher in heart and skeletal muscle, which matches StatPearls: “ALT is more liver-specific.”
Show data: nTPM values for the eight genes
| Gene | Liver | Gallbladder | Heart muscle | Skeletal muscle | Kidney | Small intestine | Placenta | Cerebral cortex | Bone marrow | HPA category |
|---|---|---|---|---|---|---|---|---|---|---|
| GPT (ALT1) | 183 | 2.3 | 40 | 47 | 15 | 17 | 0.1 | 4.2 | 2.2 | Tissue enhanced |
| GPT2 (ALT2) | 97 | 9.2 | 7.2 | 165 | 22 | 3.2 | 2.9 | 52 | 3.6 | Tissue enhanced |
| GOT1 (AST, cytosolic) | 347 | 46 | 479 | 459 | 134 | 43 | 14 | 162 | 7.5 | Tissue enhanced |
| GOT2 (AST, mitochondrial) | 300 | 23 | 298 | 654 | 82 | 35 | 23 | 80 | 20 | Group enriched |
| ALPL (tissue-nonspecific ALP) | 52 | 3.7 | 16 | 1.0 | 43 | 7.1 | 2.9 | 14 | 4.0 | Tissue enhanced |
| ALPI (intestinal ALP) | 0.0 | 0.0 | 0.0 | 0.0 | 0.9 | 121 | 0.0 | 0.0 | 0.0 | Tissue enriched |
| ALPP (placental ALP) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 33 | 0.1 | 0.0 | Group enriched |
| GGT1 (GGT) | 104 | 44 | 6.1 | 1.8 | 150 | 75 | 2.3 | 3.9 | 11 | Tissue enhanced |
Explanation, details and sources
StatPearls describes AST as “present in multiple tissues, including skeletal muscle, myocardium, kidney, brain, leukocytes, and erythrocytes,” in cytosolic and mitochondrial forms. It places alkaline phosphatase in the canalicular membrane of hepatocytes and bile duct epithelium, and notes that ALP is also produced in bone, placenta and intestine. A concordant rise in GGT makes a hepatic or biliary source of a raised ALP more likely.
LiverTox classifies the pattern of drug-induced liver injury with the R ratio, R = (ALT ÷ ALT upper limit of normal) ÷ (ALP ÷ ALP upper limit of normal): above 5 hepatocellular, below 2 cholestatic, and 2 to 5 mixed.
Reference ranges vary by laboratory. StatPearls states that “each laboratory should establish its own reference interval based on its methodology,” so no ranges are given here.
Jogu P, Zubair M, Minter DA. Liver Function Tests. StatPearls, last update June 8, 2026; LiverTox, Roussel Uclaf Causality Assessment Method (RUCAM) in Drug Induced Liver Injury, last update May 4, 2019; Human Protein Atlas 25.1.
Dopamine, adrenaline, serotonin and melatonin are each a few enzyme steps from one amino acid
One decarboxylase, DDC, serves both chains: UniProt records it converting L-DOPA to dopamine and 5-hydroxytryptophan to serotonin.
Text version of the diagram
- THL-tyrosine to L-DOPA, the rate-limiting step of catecholamine synthesis, using tetrahydrobiopterin and oxygen; cofactor Fe2+.
- DDCL-DOPA to dopamine; also 5-hydroxytryptophan to serotonin; cofactor pyridoxal 5′-phosphate.
- DBHDopamine to noradrenaline, with ascorbate and oxygen as cosubstrates; cofactor Cu2+.
- PNMTNoradrenaline to adrenaline, with S-adenosyl-L-methionine as methyl donor.
- TPH1, TPH2L-tryptophan to 5-hydroxytryptophan, the rate-limiting step of serotonin synthesis; TPH2 is the neuron-specific form; both records list Fe2+ as cofactor and tetrahydrobiopterin and oxygen as cosubstrates.
- AANATSerotonin to N-acetylserotonin, using acetyl-CoA, the penultimate step of melatonin synthesis; controls the night–day rhythm of melatonin production in the pineal gland.
- ASMTN-acetylserotonin to melatonin, with S-adenosyl-L-methionine as methyl donor.
Explanation, details and sources
In HPA bulk tissue RNA, TH is group enriched in adrenal gland and brain and DBH is tissue enriched in adrenal gland. TPH2 is not detected in any HPA tissue RNA sample, and TPH1 is group enriched in intestine, stomach and choroid plexus.
The FDA lists melatonin as a sensitive CYP1A2 substrate; see the CYP1A2 row and the melatonin entry.
UniProtKB 2026_03 FUNCTION, COFACTOR and CATALYTIC ACTIVITY entries for the accessions above; Human Protein Atlas 25.1; U.S. FDA interaction table, May 29, 2026.
The atlas: 177 proteins by system, sorted by organ of main expression
Each gene symbol links to its reviewed UniProt entry and each HPA link to its tissue page. Function summaries restate the UniProt FUNCTION text in 25 words or fewer. A “why it matters here” note appears only where a cited human study or an FDA, NIH or LiverTox source states the link.
Digestive enzymes 21 proteins
| Protein | EC number | Function (UniProt, summarized) | Location in the cell (UniProt) | Main expression (HPA tissue RNA) | Why it matters here |
|---|---|---|---|---|---|
| ANPEP aminopeptidase NAminopeptidase NUniProt P15144 | EC 3.4.11.2 | Broad-specificity aminopeptidase in the final digestion of peptides from gastric and pancreatic proteolysis; also processes peptide hormones. | Cell membrane | Esophagus, stomach and intestine Group enriched: intestine 2,245, pancreas 644 nTPM HPA UniProt: “Expressed in epithelial cells of the kidney, intestine, and respiratory tract …” | — |
| LCT lactaseLactase/phlorizin hydrolaseUniProt P09848 | EC 3.2.1.108 +1 more | Brush-border glycosidase that hydrolyzes lactose to glucose and galactose. | Apical cell membrane | Esophagus, stomach and intestine Tissue enriched: intestine 213 nTPM HPA UniProt: “Specifically expressed in small intestine” | — |
| LIPF gastric lipaseGastric triacylglycerol lipaseUniProt P07098 | EC 3.1.1.3 | Hydrolyzes triacylglycerols to free fatty acids, diacylglycerol, monoacylglycerol and glycerol, preferring the sn-3 position. | Secreted | Esophagus, stomach and intestine Tissue enriched: stomach 35,390 nTPM HPA | — |
| MGAM maltase-glucoamylaseMaltase-glucoamylaseUniProt O43451 | EC 3.2.1.20 | α-1,4 exo-glucosidase that releases glucose from the non-reducing end of starch-derived dextrins in the small intestine. | Apical cell membrane | Esophagus, stomach and intestine Tissue enhanced: intestine 82, epididymis 24 nTPM HPA UniProt: “Broadly expressed …” | — |
| PGA3 pepsinogen APepsin A-3UniProt P0DJD8 | EC 3.4.23.1 | Pepsin with particularly broad specificity; prefers bonds involving phenylalanine and leucine but cleaves many others to some extent. | Secreted | Esophagus, stomach and intestine Tissue enriched: stomach 63,358 nTPM HPA | — |
| PGC gastricsinGastricsinUniProt P20142 | EC 3.4.23.3 | Gastricsin; hydrolyzes a variety of proteins. | Secreted | Esophagus, stomach and intestine Tissue enriched: stomach 57,584 nTPM HPA | — |
| SI sucrase-isomaltaseSucrase-isomaltase, intestinalUniProt P14410 | EC 3.2.1.48 +1 more | Small-intestinal enzyme with sucrase and isomaltase domains; cleaves sucrose to glucose and fructose and the α-1,6 linkages of isomaltose. | Apical cell membrane | Esophagus, stomach and intestine Tissue enriched: intestine 513 nTPM HPA UniProt: “Expressed in the poorly differentiated crypt cells of the small intestine as well as in the mature villous cells …” | — |
| TMPRSS15 enteropeptidaseEnteropeptidaseUniProt P98073 | EC 3.4.21.9 | Converts trypsinogen to trypsin, which then activates chymotrypsinogen, procarboxypeptidases and proelastases. | Membrane | Esophagus, stomach and intestine Tissue enriched: intestine 922 nTPM HPA UniProt: “Intestinal brush border” | — |
| TREH trehalaseTrehalaseUniProt O43280 | EC 3.2.1.28 | Intestinal trehalase, probably involved in hydrolyzing ingested trehalose. | Cell membrane | Esophagus, stomach and intestine Tissue enriched: intestine 62 nTPM HPA UniProt: “Expressed in kidney, liver and small intestine …” | — |
| AMY2A pancreatic amylasePancreatic alpha-amylaseUniProt P04746 | EC 3.2.1.1 | Pancreatic α-amylase; catalyzes endohydrolysis of α-1,4-glucosidic linkages in polysaccharides of three or more glucose units (UniProt catalytic activity). | Secreted, extracellular space | Pancreas Tissue enriched: pancreas 145,041 nTPM HPA UniProt: “Detected in pancreas (at protein level)” | — |
| CEL bile salt-activated lipaseBile salt-activated lipaseUniProt P19835 | EC 3.1.1.13 EC 3.1.1.3 EC 3.1.1.6 | Hydrolyzes cholesteryl esters, phospholipids, lysophospholipids, di- and triacylglycerols and fatty acid esters of hydroxy fatty acids. | Secreted | Pancreas Tissue enriched: pancreas 104,265 nTPM HPA UniProt: “Mammary gland and pancreas …” | — |
| CELA3A elastase 3AChymotrypsin-like elastase family member 3AUniProt P09093 | EC 3.4.21.70 | Protease with alanine specificity and little elastolytic activity. | Not annotated | Pancreas Tissue enriched: pancreas 247,620 nTPM HPA | — |
| CLPS colipaseColipaseUniProt P04118 | — | Cofactor that anchors pancreatic lipase to the lipid–water interface; without it bile salts wash the lipase off. | Secreted | Pancreas Tissue enriched: pancreas 246,874 nTPM HPA UniProt: “Expressed by the pancreas” | — |
| CPA1 carboxypeptidase A1Carboxypeptidase A1UniProt P15085 | EC 3.4.17.1 | Releases C-terminal amino acids, with little or no action on aspartate, glutamate, arginine, lysine or proline. | Secreted | Pancreas Tissue enriched: pancreas 223,994 nTPM HPA | — |
| CPB1 carboxypeptidase BCarboxypeptidase BUniProt P15086 | EC 3.4.17.2 | Preferentially releases a C-terminal lysine or arginine (UniProt catalytic activity). | Secreted; Zymogen granule lumen | Pancreas Tissue enriched: pancreas 213,987 nTPM HPA UniProt: “Pancreas” | — |
| CTRB1 chymotrypsinogen BChymotrypsinogen BUniProt P17538 | EC 3.4.21.1 | Chymotrypsin; preferentially cleaves after tyrosine, tryptophan, phenylalanine and leucine (UniProt catalytic activity). | Secreted, extracellular space | Pancreas Tissue enriched: pancreas 126,233 nTPM HPA | — |
| PLA2G1B pancreatic phospholipase A2Phospholipase A2UniProt P04054 | EC 3.1.1.4 | Calcium-dependent secreted phospholipase A2 that hydrolyzes the sn-2 ester of dietary phospholipids in the intestinal tract. | Secreted | Pancreas Tissue enriched: pancreas 110,914 nTPM HPA UniProt: “Selectively expressed in pancreas, lung, liver and kidney …” | — |
| PNLIP pancreatic lipasePancreatic triacylglycerol lipaseUniProt P16233 | EC 3.1.1.3 | Splits long-chain fatty acid esters at positions 1 and 3, giving mainly 2-monoacylglycerol and free fatty acids; most active on emulsified substrates. | Secreted | Pancreas Tissue enriched: pancreas 419,356 nTPM HPA | — |
| PRSS1 trypsin-1Serine protease 1UniProt P07477 | EC 3.4.21.4 | Trypsin-1, a serine protease active on synthetic peptide substrates; the single-chain form is more active than the two-chain form. | Secreted, extracellular space | Pancreas Tissue enriched: pancreas 319,717 nTPM HPA | — |
| AMY1A salivary amylaseAlpha-amylase 1AUniProt P0DUB6 | EC 3.2.1.1 | Calcium-binding enzyme that starts starch digestion in the mouth, hydrolyzing internal α-1,4 glucosidic bonds to maltose, isomaltose, glucose and dextrins. | Secreted | Salivary gland Tissue enriched: salivary gland 7,769 nTPM HPA | — |
| DPP4 dipeptidyl peptidase 4Dipeptidyl peptidase 4UniProt P27487 | EC 3.4.14.5 | Cell-surface T-cell costimulatory receptor and serine exopeptidase that removes N-terminal dipeptides from chemokines, growth factors, neuropeptides and peptide hormones. | Secreted; Cell membrane; Apical cell membrane; +4 more | Endocrine glands Tissue enhanced: parathyroid gland 147, intestine 130, placenta 126, prostate 101 nTPM HPA UniProt: “Expressed specifically in lymphatic vessels but not in blood vessels in the skin, small intestine, esophagus, ovary, breast and prostate glands …” | — |
Phase I metabolism 24 proteins
| Protein | EC number | Function (UniProt, summarized) | Location in the cell (UniProt) | Main expression (HPA tissue RNA) | Why it matters here |
|---|---|---|---|---|---|
| ADH1BAll-trans-retinol dehydrogenase [NAD(+)] ADH1BUniProt P00325 | EC 1.1.1.105 | NAD-dependent oxidation of all-trans-retinol and its derivatives; may take part in retinoid metabolism. | Cytoplasm | Liver and gallbladder Tissue enhanced: liver 5,476, adipose tissue 1,409 nTPM HPA | — |
| ALDH2Aldehyde dehydrogenase, mitochondrialUniProt P05091 | EC 1.2.1.19 EC 1.2.1.24 EC 1.2.1.3 EC 1.2.1.36 EC 1.2.1.46 +1 more | Mitochondrial aldehyde dehydrogenase that detoxifies ethanol-derived acetaldehyde and endogenous aldehydes, including lipid-peroxidation products and formaldehyde. | Mitochondrion | Liver and gallbladder Tissue enhanced: liver 801 nTPM HPA | — |
| AOX1 aldehyde oxidaseAldehyde oxidaseUniProt Q06278 | EC 1.2.3.1 +3 more | Oxidizes a broad range of drugs and xenobiotics, including aldehydes and aromatic azaheterocycles, using molecular oxygen and releasing hydrogen peroxide. | Cytoplasm | Liver and gallbladder Group enriched: liver 833, adrenal gland 284 nTPM HPA UniProt: “Abundant in liver, expressed in adipose tissue and at lower levels in lung, skeletal muscle, pancreas …” | — |
| CES1Liver carboxylesterase 1UniProt P23141 | EC 3.1.1.1 +2 more | Detoxifies xenobiotics and activates ester and amide prodrugs by hydrolyzing aromatic and aliphatic esters; also hydrolyzes cholesteryl esters. | Endoplasmic reticulum lumen; Cytoplasm; Lipid droplet | Liver and gallbladder Tissue enriched: liver 2,354 nTPM HPA UniProt: “Expressed predominantly in liver with lower levels in heart and lung …” | — |
| CYP1A1Cytochrome P450 1A1UniProt P04798 | EC 1.14.14.1 +1 more | Monooxygenase for fatty acids, steroid hormones and vitamins; forms hydroxyestrogens and epoxidizes polyunsaturated fatty acids, using NADPH via P450 reductase. | Endoplasmic reticulum membrane; Mitochondrion inner membrane; Microsome membrane; +1 more | Liver and gallbladder Tissue enhanced: liver 62, urinary bladder 60 nTPM HPA UniProt: “Lung, lymphocytes and placenta” | — |
| CYP1A2Cytochrome P450 1A2UniProt P05177 | EC 1.14.14.1 +1 more | Monooxygenase for fatty acids, steroids and vitamins; plays a role in xenobiotic oxidation and probably metabolizes caffeine by N3-demethylation. | Endoplasmic reticulum membrane; Microsome membrane | Liver and gallbladder Tissue enriched: liver 478 nTPM HPA UniProt: “Liver” | FDA FDA lists caffeine and melatonin as sensitive CYP1A2 substrates and tobacco smoking as a moderate CYP1A2 inducer. FDA table, May 29, 2026 Supplements A–Z: Caffeine, Melatonin |
| CYP2A6Cytochrome P450 2A6UniProt P11509 | EC 1.14.14.- | High coumarin 7-hydroxylase activity; the major nicotine C-oxidase; hydroxylates cyclophosphamide, ifosfamide and tegafur and activates aflatoxin B1. | Endoplasmic reticulum membrane; Microsome membrane | Liver and gallbladder Tissue enriched: liver 1,508 nTPM HPA UniProt: “Liver” | — |
| CYP2B6Cytochrome P450 2B6UniProt P20813 | EC 1.14.13.- | Monooxygenase for endocannabinoids and steroids; plays a role in oxidative metabolism of xenobiotics, including plant lipids and drugs. | Endoplasmic reticulum membrane; Microsome membrane | Liver and gallbladder Tissue enriched: liver 550 nTPM HPA UniProt: “Expressed in liver, lung and heart right ventricle” | FDA One of seven CYPs in FDA's clinical interaction table (efavirenz: moderately sensitive substrate). FDA table, May 29, 2026 |
| CYP2C19Cytochrome P450 2C19UniProt P33261 | EC 1.14.14.1 +4 more | Monooxygenase for polyunsaturated fatty acids; metabolizes S-mephenytoin, omeprazole, proguanil, diazepam, propranolol, citalopram and imipramine. | Endoplasmic reticulum membrane; Microsome membrane | Liver and gallbladder Tissue enriched: liver 178 nTPM HPA | FDA One of seven CYPs in FDA's clinical interaction table (omeprazole: sensitive substrate). FDA table, May 29, 2026 |
| CYP2C8Cytochrome P450 2C8UniProt P10632 | EC 1.14.14.1 | Monooxygenase that epoxidizes polyunsaturated fatty acids, hydroxylates retinoic acid and estrogens, and is the principal enzyme metabolizing paclitaxel. | Endoplasmic reticulum membrane; Microsome membrane | Liver and gallbladder Tissue enriched: liver 2,014 nTPM HPA | FDA One of seven CYPs in FDA's clinical interaction table (repaglinide: sensitive substrate). FDA table, May 29, 2026 |
| CYP2C9Cytochrome P450 2C9UniProt P11712 | EC 1.14.14.1 +3 more | Monooxygenase for fatty acids and steroids, also oxygenates limonene; contributes to the wide variability in metabolism of drugs such as S-warfarin. | Endoplasmic reticulum membrane; Microsome membrane | Liver and gallbladder Tissue enriched: liver 1,608 nTPM HPA | FDA FDA lists the supplement diosmin as a weak CYP2C9 inhibitor; S-warfarin is a moderately sensitive substrate. FDA table, May 29, 2026 |
| CYP2D6Cytochrome P450 2D6UniProt P10635 | EC 1.14.14.- | Monooxygenase for fatty acids, steroids and retinoids; oxidizes drugs such as antiarrhythmics, adrenoceptor antagonists and tricyclic antidepressants. | Endoplasmic reticulum membrane; Microsome membrane | Liver and gallbladder Tissue enriched: liver 386 nTPM HPA | FDA One of seven CYPs in FDA's clinical interaction table (dextromethorphan: sensitive substrate). FDA table, May 29, 2026 |
| CYP2E1Cytochrome P450 2E1UniProt P05181 | EC 1.14.14.1 +1 more | Monooxygenase that hydroxylates fatty acids at the omega-1 position; may be involved in oxidative metabolism of xenobiotics. | Endoplasmic reticulum membrane; Microsome membrane; Mitochondrion inner membrane | Liver and gallbladder Tissue enriched: liver 9,697 nTPM HPA | — |
| CYP2J2Cytochrome P450 2J2UniProt P51589 | EC 1.14.14.- +3 more | Monooxygenase that epoxidizes arachidonic acid and other polyunsaturated fatty acids in the cardiovascular system; also oxidizes xenobiotics. | Endoplasmic reticulum membrane; Microsome membrane | Liver and gallbladder Group enriched: liver 137, heart muscle 84, intestine 78 nTPM HPA UniProt: “Highly expressed in heart, present at lower levels in liver, kidney and skeletal muscle (at protein level)” | — |
| CYP3A4Cytochrome P450 3A4UniProt P08684 | EC 1.14.14.1 +3 more | Monooxygenase for sterols, steroid hormones, retinoids and fatty acids; responsible for oxidative metabolism of xenobiotics, including the majority of administered drugs. | Endoplasmic reticulum membrane; Microsome membrane | Liver and gallbladder Tissue enriched: liver 3,367 nTPM HPA UniProt: “Expressed in prostate and liver …” | Human study FDA lists St John's wort as a strong CYP3A inducer, its effect “preparation dependent”; in 42 men, induction tracked hyperforin dose. Goldenseal raised midazolam AUC 1.43-fold. FDA table, May 29, 2026; Mueller 2006; Nguyen 2021 Supplements A–Z: St. John's wort, Goldenseal |
| CYP3A5Cytochrome P450 3A5UniProt P20815 | EC 1.14.14.1 | Monooxygenase for steroid hormones and vitamin A (retinol, retinoic acid); also oxidizes xenobiotics, including nifedipine and cyclosporine. | Endoplasmic reticulum membrane; Microsome membrane | Liver and gallbladder Tissue enhanced: liver 319, intestine 167 nTPM HPA | FDA FDA's interaction table lists “3A” as one class and does not name CYP3A4 or CYP3A5 separately (midazolam: sensitive substrate). FDA table, May 29, 2026 |
| EPHX1 microsomal epoxide hydrolaseEpoxide hydrolase 1UniProt P07099 | EC 3.3.2.9 | Hydrolyzes arene and aliphatic epoxides to less reactive, more water-soluble dihydrodiols; also metabolizes epoxide-containing lipids. | Microsome membrane; Endoplasmic reticulum membrane | Liver and gallbladder Tissue enhanced: liver 1,594, adrenal gland 1,147 nTPM HPA UniProt: “Found in liver” | — |
| FMO3Flavin-containing monooxygenase 3UniProt P31513 | EC 1.14.13.148 EC 1.14.13.32 EC 1.14.13.8 | Hepatic enzyme oxygenating nitrogen- and sulfur-containing drugs and dietary compounds; converts gut-derived trimethylamine (from choline, betaine or L-carnitine) to TMAO. | Microsome membrane; Endoplasmic reticulum membrane | Liver and gallbladder Tissue enriched: liver 1,050 nTPM HPA UniProt: “Liver” | Supplements A–Z: Choline, L-carnitine |
| MAOB MAO-BAmine oxidase [flavin-containing] BUniProt P27338 | EC 1.4.3.21 EC 1.4.3.4 | Oxidatively deaminates amine neurotransmitters and exogenous amines such as MPTP; prefers benzylamine and phenylethylamine. | Mitochondrion outer membrane | Liver and gallbladder Tissue enhanced: liver 297 nTPM HPA | — |
| POR P450 oxidoreductaseNADPH--cytochrome P450 reductaseUniProt P16435 | EC 1.6.2.4 | Transfers electrons from NADPH to microsomal cytochrome P450 enzymes; can also supply heme oxygenase and cytochrome b5. | Endoplasmic reticulum membrane | Liver and gallbladder Tissue enhanced: liver 293 nTPM HPA | — |
| XDH xanthine oxidoreductaseXanthine dehydrogenase/oxidaseUniProt P47989 | EC 1.17.1.4 +1 more | Key enzyme of purine degradation: oxidizes hypoxanthine to xanthine and xanthine to uric acid; contributes to reactive oxygen species. | Cytoplasm; Peroxisome; Secreted | Liver and gallbladder Group enriched: liver 64, intestine 47, breast 39 nTPM HPA UniProt: “Detected in milk (at protein level)” | — |
| CES2Cocaine esteraseUniProt O00748 | EC 3.1.1.84 +2 more | Detoxifies xenobiotics and activates ester and amide prodrugs; hydrolyzes cocaine, heroin, aspirin and triacylglycerols. | Endoplasmic reticulum lumen | Esophagus, stomach and intestine Tissue enhanced: intestine 662, liver 323 nTPM HPA UniProt: “Preferentially expressed in intestine with moderate expression in liver …” | — |
| MAOA MAO-AAmine oxidase [flavin-containing] AUniProt P21397 | EC 1.4.3.21 EC 1.4.3.4 | Oxidatively deaminates amine neurotransmitters, producing hydrogen peroxide; preferentially oxidizes serotonin. | Mitochondrion outer membrane | Esophagus, stomach and intestine Tissue enhanced: intestine 206 nTPM HPA UniProt: “Heart, liver, duodenum, blood vessels and kidney” | — |
| CYP1B1Cytochrome P450 1B1UniProt Q16678 | EC 1.14.14.1 +1 more | Monooxygenase for estrogens, steroids, retinoids and fatty acids; converts polycyclic aromatic hydrocarbon and aryl amine procarcinogens to DNA-damaging products. | Endoplasmic reticulum membrane; Microsome membrane; Mitochondrion | Many tissues (low tissue specificity) Low tissue specificity; detected in many; highest fallopian tube 42 nTPM HPA UniProt: “Expressed in heart, brain, lung, skeletal muscle, kidney, spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes …” | — |
Phase II conjugation 21 proteins
| Protein | EC number | Function (UniProt, summarized) | Location in the cell (UniProt) | Main expression (HPA tissue RNA) | Why it matters here |
|---|---|---|---|---|---|
| GSTA1Glutathione S-transferase A1UniProt P08263 | EC 2.5.1.18 +2 more | Glutathione S-transferase that attaches glutathione to electrophilic groups of many exogenous and endogenous compounds. | Cytoplasm | Liver and gallbladder Tissue enhanced: liver 2,439, kidney 880, adrenal gland 636, intestine 636 nTPM HPA UniProt: “Liver” | — |
| GSTM1Glutathione S-transferase Mu 1UniProt P09488 | EC 2.5.1.18 | Conjugates reduced glutathione to many exogenous and endogenous hydrophobic electrophiles. | Cytoplasm | Liver and gallbladder Tissue enhanced: liver 570 nTPM HPA UniProt: “Liver (at protein level)” | — |
| NAT2Arylamine N-acetyltransferase 2UniProt P11245 | EC 2.3.1.5 +1 more | N- or O-acetylates arylamines and heterocyclic amines; detoxifies hydrazine and arylamine drugs and can bioactivate some carcinogens. | Cytoplasm | Liver and gallbladder Group enriched: liver 120, intestine 32 nTPM HPA | — |
| NNMTNicotinamide N-methyltransferaseUniProt P40261 | EC 2.1.1.1 | N-methylates nicotinamide to N1-methylnicotinamide using S-adenosyl-L-methionine, a predominant clearance pathway for nicotinamide (vitamin B3). | Cytoplasm | Liver and gallbladder Tissue enriched: liver 297 nTPM HPA UniProt: “Predominantly expressed in the liver …” | Supplements A–Z: Niacin (vitamin B3) |
| SULT1A1Sulfotransferase 1A1UniProt P50225 | EC 2.8.2.1 | Uses PAPS to sulfate many hydroxyl- or amine-bearing molecules, mostly small phenols; sulfation usually aids renal excretion but can bioactivate. | Cytoplasm | Liver and gallbladder Tissue enhanced: liver 191, intestine 105 nTPM HPA UniProt: “Liver, lung, adrenal, brain, platelets and skin” | — |
| SULT1E1Sulfotransferase 1E1UniProt P49888 | EC 2.8.2.4 | Uses PAPS to sulfate and inactivate estradiol and estrone; a key enzyme of estrogen homeostasis. | Cytoplasm, cytosol | Liver and gallbladder Tissue enhanced: liver 35, vagina 29, intestine 26, skin 18 nTPM HPA UniProt: “Liver, intestine and at lower level in the kidney” | — |
| SULT2A1Sulfotransferase 2A1UniProt Q06520 | EC 2.8.2.2 +1 more | Uses PAPS to sulfonate steroids and bile acids in the liver and adrenal glands. | Cytoplasm | Liver and gallbladder Tissue enriched: liver 1,005 nTPM HPA UniProt: “Liver, adrenal and at lower level in the kidney …” | — |
| UGT1A1UDP-glucuronosyltransferase 1A1UniProt P22309 | EC 2.4.1.17 | Conjugates lipophilic substrates with glucuronic acid for urinary or biliary excretion; glucuronidates bilirubin, estrogens and isoflavones such as genistein and daidzein. | Endoplasmic reticulum membrane; Cytoplasm, perinuclear region | Liver and gallbladder Group enriched: liver 345, intestine 189 nTPM HPA UniProt: “Expressed in liver, colon and small intestine …” | — |
| UGT1A3UDP-glucuronosyltransferase 1A3UniProt P35503 | EC 2.4.1.17 | Glucuronidates drugs, xenobiotics and endogenous compounds to aid their elimination; acts on the phytochemical ferulic acid. | Endoplasmic reticulum membrane | Liver and gallbladder Tissue enriched: liver 64 nTPM HPA UniProt: “Expressed in liver, kidney, colon, esophagus and small intestine Expressed in liver, kidney and colon …” | — |
| UGT1A4UDP-glucuronosyltransferase 1A4UniProt P22310 | EC 2.4.1.17 | Glucuronidates drugs and xenobiotics; catalyzes N-glucuronidation of tobacco alkaloids, nitrosamines and tricyclic antidepressants. | Endoplasmic reticulum membrane | Liver and gallbladder Tissue enriched: liver 368 nTPM HPA UniProt: “Expressed in liver …” | — |
| UGT1A6UDP-glucuronosyltransferase 1A6UniProt P19224 | EC 2.4.1.17 | Glucuronidates small planar phenols such as 1-naphthol and 4-methylumbelliferone, and ferulic acid; bulky phenols, androgens and estrogens are not substrates. | Microsome; Endoplasmic reticulum membrane | Liver and gallbladder Group enriched: liver 134, urinary bladder 83, kidney 66 nTPM HPA UniProt: “Expressed in skin …” | — |
| UGT2B15UDP-glucuronosyltransferase 2B15UniProt P54855 | EC 2.4.1.17 | Glucuronidates drugs and xenobiotics and the steroid hormones testosterone, androsterone and estrogens. | Endoplasmic reticulum membrane | Liver and gallbladder Group enriched: liver 272, gallbladder 73 nTPM HPA UniProt: “Expressed in many tissues …” | — |
| UGT2B7UDP-glucuronosyltransferase 2B7UniProt P16662 | EC 2.4.1.17 | Glucuronidates drugs, xenobiotics, androgens, estrogens, retinoic acid, bile acids and eicosanoids to aid their excretion. | Endoplasmic reticulum membrane | Liver and gallbladder Group enriched: liver 1,507, kidney 1,213 nTPM HPA | — |
| GSTP1Glutathione S-transferase PUniProt P09211 | EC 2.5.1.18 | Conjugates reduced glutathione to many exogenous and endogenous hydrophobic electrophiles. | Cytoplasm; Mitochondrion; Nucleus | Esophagus, stomach and intestine Tissue enhanced: esophagus 2,859 nTPM HPA | — |
| SULT1A3Sulfotransferase 1A3UniProt P0DMM9 | EC 2.8.2.1 | Uses PAPS to sulfate phenolic monoamine neurotransmitters such as dopamine, adrenaline and serotonin, and phenolic and catechol drugs. | Cytoplasm | Esophagus, stomach and intestine Tissue enriched: intestine 226 nTPM HPA UniProt: “Liver, colon, kidney, lung, brain, spleen, small intestine, placenta and leukocyte” | — |
| UGT2B17UDP-glucuronosyltransferase 2B17UniProt O75795 | EC 2.4.1.17 | Glucuronidates androgens such as epitestosterone and androsterone, and estrogens, increasing water solubility to aid excretion in urine or bile. | Endoplasmic reticulum membrane | Esophagus, stomach and intestine Group enriched: intestine 357, liver 104 nTPM HPA UniProt: “Expressed in various tissues including the liver, kidney, testis, uterus, placenta, mammary gland, adrenal gland, skin and prostate” | — |
| UGT1A9UDP-glucuronosyltransferase 1A9UniProt O60656 | EC 2.4.1.17 | Glucuronidates drugs and xenobiotics; acts efficiently on ferulic acid and on isoflavones including genistein, daidzein and biochanin A. | Endoplasmic reticulum membrane | Kidney and bladder Group enriched: kidney 428, liver 184 nTPM HPA UniProt: “Expressed in liver, kidney, colon, esophagus and small intestine” | — |
| TPMTThiopurine S-methyltransferaseUniProt P51580 | EC 2.1.1.67 | S-methylates thiopurine drugs such as 6-mercaptopurine and 6-thioguanine using S-adenosyl-L-methionine; its activity modulates their cytotoxic effects. | Cytoplasm | Endocrine glands Tissue enhanced: thyroid gland 72, kidney 71, liver 64 nTPM HPA | — |
| COMTCatechol O-methyltransferaseUniProt P21964 | EC 2.1.1.6 | O-methylates and thereby inactivates catecholamine neurotransmitters and catechol hormones; shortens half-lives of L-DOPA, α-methyl DOPA and isoproterenol. | Cytoplasm; Cell membrane | Many tissues (low tissue specificity) Low tissue specificity; detected in all; highest liver 268 nTPM HPA UniProt: “Brain, liver, placenta, lymphocytes and erythrocytes” | — |
| NAT1Arylamine N-acetyltransferase 1UniProt P18440 | EC 2.3.1.5 +2 more | N-acetylates (usually detoxifying) and O-acetylates (usually bioactivating) hydrazines, aromatic amine drugs and aromatic amine carcinogens, using acetyl-CoA. | Cytoplasm | Many tissues (low tissue specificity) Low tissue specificity; detected in many; highest epididymis 14 nTPM HPA | — |
| GSTT1Glutathione S-transferase theta-1UniProt P30711 | EC 2.5.1.18 | Conjugates reduced glutathione to hydrophobic electrophiles; also shows glutathione peroxidase activity with cumene hydroperoxide. | Cytoplasm | Not detected or not in HPA Not found in the HPA search for this gene symbol. UniProt: “Found in erythrocyte …” | — |
Transporters 31 proteins
| Protein | EC number | Function (UniProt, summarized) | Location in the cell (UniProt) | Main expression (HPA tissue RNA) | Why it matters here |
|---|---|---|---|---|---|
| ABCB11 BSEPBile salt export pumpUniProt O95342 | EC 7.6.2.- | Bile salt export pump: moves taurine- and glycine-conjugated bile salts across the hepatocyte canalicular membrane, using ATP. | Apical cell membrane; Recycling endosome membrane; Endosome; +1 more | Liver and gallbladder Tissue enriched: liver 75 nTPM HPA UniProt: “Expressed predominantly, if not exclusively in the liver, where it was further localized to the canalicular microvilli and to subcanalicular vesicles of the …” | — |
| ABCC2 MRP2ATP-binding cassette sub-family C member 2UniProt Q92887 | EC 7.6.2.- EC 7.6.2.2 EC 7.6.2.3 | ATP-dependent transporter at apical membranes of hepatocytes and renal and intestinal cells, exporting glucuronide, glutathione and sulfate conjugates. | Apical cell membrane | Liver and gallbladder Tissue enhanced: liver 114, intestine 38 nTPM HPA UniProt: “Expressed by polarized cells in liver, kidney and intestine …” | — |
| SLC10A1 NTCPHepatic sodium/bile acid cotransporterUniProt Q14973 | — | Sodium-dependent uptake of conjugated bile salts from plasma into hepatocytes, central to enterohepatic circulation of bile salts. | Cell membrane | Liver and gallbladder Tissue enriched: liver 399 nTPM HPA UniProt: “Expressed in liver …” | — |
| SLC22A1 OCT1Solute carrier family 22 member 1UniProt O15245 | — | Electrogenic uniporter for organic cations, including bioactive amines and cationic drugs; involved in hepatic uptake of thiamine. | Basolateral cell membrane; Apical cell membrane; Lateral cell membrane; +2 more | Liver and gallbladder Tissue enriched: liver 596 nTPM HPA UniProt: “Widely expressed with high level in liver …” | Supplements A–Z: Thiamin (vitamin B1) |
| SLC2A2 GLUT2Solute carrier family 2, facilitated glucose transporter member 2UniProt P11168 | — | Facilitative transporter of glucose, fructose and galactose; likely mediates bidirectional glucose transfer across the hepatocyte membrane. | Cell membrane | Liver and gallbladder Tissue enriched: liver 782 nTPM HPA UniProt: “Liver, insulin-producing beta cell, small intestine and kidney” | — |
| SLCO1B1 OATP1B1Solute carrier organic anion transporter family member 1B1UniProt Q9Y6L6 | — | Sodium-independent uptake of organic anions, including bile acids, conjugated steroids, bilirubin glucuronides and statins such as pravastatin and pitavastatin. | Basolateral cell membrane; Basal cell membrane | Liver and gallbladder Tissue enriched: liver 502 nTPM HPA UniProt: “Highly expressed in liver, at the basolateral membranes of centrilobular hepatocytes …” | Human study In FDA's transporter table (rosuvastatin: substrate). A goldenseal product did not change rosuvastatin pharmacokinetics in 16 healthy volunteers. FDA table, May 29, 2026; Nguyen 2021 Supplements A–Z: Goldenseal |
| SLCO1B3 OATP1B3Solute carrier organic anion transporter family member 1B3UniProt Q9NPD5 | — | Sodium-independent uptake of organic anions, including bile acids, conjugated steroids, bilirubin glucuronides and statins such as pitavastatin. | Basolateral cell membrane; Basal cell membrane | Liver and gallbladder Tissue enriched: liver 248 nTPM HPA UniProt: “Highly expressed in liver, in particular at the basolateral membrane of hepatocytes near the central vein …” | Human study In FDA's transporter table (rosuvastatin: substrate). A goldenseal product did not change rosuvastatin pharmacokinetics in 16 healthy volunteers. FDA table, May 29, 2026; Nguyen 2021 Supplements A–Z: Goldenseal |
| SLCO2B1 OATP2B1Solute carrier organic anion transporter family member 2B1UniProt O94956 | — | Sodium-independent transport of steroid sulfate conjugates and other specific organic anions. | Cell membrane; Basal cell membrane; Basolateral cell membrane; +1 more | Liver and gallbladder Tissue enhanced: liver 214 nTPM HPA UniProt: “Strongly expressed in the liver, at the sinusoidal membrane of the hepatocytes …” | — |
| ABCG2 BCRPBroad substrate specificity ATP-binding cassette transporter ABCG2UniProt Q9UNQ0 | EC 7.6.2.- EC 7.6.2.2 | ATP-dependent efflux transporter of many physiological compounds, dietary toxins and xenobiotics; exports urate, heme and sulfate conjugates. | Cell membrane; Apical cell membrane; Mitochondrion membrane | Esophagus, stomach and intestine Tissue enhanced: intestine 83 nTPM HPA UniProt: “Highly expressed in placenta …” | FDA FDA lists curcumin, a supplement, as a BCRP inhibitor (rosuvastatin, sulfasalazine: substrates). FDA table, May 29, 2026 Supplements A–Z: Turmeric (and curcumin) |
| NPC1L1NPC1-like intracellular cholesterol transporter 1UniProt Q9UHC9 | — | Takes up cholesterol across the enterocyte membrane and transports plant sterols such as sitosterol at lower rates; direct target of ezetimibe. | Apical cell membrane; Cell membrane; Cytoplasmic vesicle membrane | Esophagus, stomach and intestine Group enriched: intestine 51, liver 47 nTPM HPA UniProt: “Widely expressed …” | — |
| SLC15A1 PepT1Solute carrier family 15 member 1UniProt P46059 | — | Proton-coupled transporter of di-, tri- and tetrapeptides, preferring dipeptides. | Apical cell membrane | Esophagus, stomach and intestine Tissue enriched: intestine 191 nTPM HPA UniProt: “Expressed in small intestine” | — |
| SLC23A1 SVCT1Solute carrier family 23 member 1UniProt Q9UHI7 | — | Sodium-coupled (2 Na⁺ per ascorbate) uptake of vitamin C. | Cell membrane | Esophagus, stomach and intestine Group enriched: intestine 62, fallopian tube 51, kidney 38, liver 21 nTPM HPA UniProt: “Highly expressed in adult small intestine, kidney, thymus, ovary, colon, prostate and liver, and in fetal kidney, liver and thymus” | Supplements A–Z: Vitamin C |
| SLC2A5 GLUT5Solute carrier family 2, facilitated glucose transporter member 5UniProt P22732 | — | Fructose transporter with low activity toward other monosaccharides; essential for fructose uptake in the small intestine. | Apical cell membrane; Cell membrane; Cell membrane, sarcolemma | Esophagus, stomach and intestine Tissue enhanced: intestine 103, bone marrow 92, skeletal muscle 74, testis 71 nTPM HPA UniProt: “Detected in skeletal muscle, and in jejunum brush border membrane and basolateral membrane (at protein level) …” | — |
| SLC39A4 ZIP4Zinc transporter ZIP4UniProt Q6P5W5 | — | Selective Zn²⁺ uptake transporter, essential for dietary zinc uptake from the small intestine. | Cell membrane; Recycling endosome membrane; Apical cell membrane | Esophagus, stomach and intestine Tissue enriched: intestine 83 nTPM HPA UniProt: “Highly expressed in kidney, small intestine, stomach, colon, jejunum and duodenum” | Supplements A–Z: Zinc |
| SLC46A1 PCFTProton-coupled folate transporterUniProt Q96NT5 | — | Proton-coupled folate symporter that mediates folate absorption. | Cell membrane; Apical cell membrane; Basolateral cell membrane; +2 more | Esophagus, stomach and intestine Tissue enhanced: intestine 88 nTPM HPA UniProt: “Expressed at highest level in the upper half of the small intestine (duodenum and jejunum), expression decreases downwardly in the subsequent quarter and is …” | Supplements A–Z: Folate (folic acid) |
| SLC5A1 SGLT1Sodium/glucose cotransporter 1UniProt P13866 | — | Sodium-coupled symporter (2 Na⁺ per sugar) that actively transports D-glucose or D-galactose. | Apical cell membrane | Esophagus, stomach and intestine Tissue enriched: intestine 498 nTPM HPA UniProt: “Expressed in intestine …” | — |
| SLC22A2 OCT2Solute carrier family 22 member 2UniProt O15244 | — | Electrogenic, sodium-independent, bidirectional uniporter for organic cations, including endogenous amines and cationic drugs. | Basolateral cell membrane; Basal cell membrane; Apical cell membrane | Kidney and bladder Tissue enriched: kidney 144 nTPM HPA UniProt: “Mainly expressed in kidney, in the cortex and medulla …” | Human study In FDA's transporter table (metformin: substrate). A goldenseal product lowered metformin AUC to 0.77-fold in 16 healthy volunteers, without changing renal clearance. FDA table, May 29, 2026; Nguyen 2021 Supplements A–Z: Goldenseal |
| SLC22A6 OAT1Solute carrier family 22 member 6UniProt Q4U2R8 | — | Organic anion/dicarboxylate exchanger (OAT1); takes up organic anions, including uremic toxins and urate, in exchange for 2-oxoglutarate. | Basolateral cell membrane; Basal cell membrane | Kidney and bladder Tissue enriched: kidney 184 nTPM HPA UniProt: “Strongly expressed in kidney …” | Human study In FDA's transporter table. A goldenseal product did not change furosemide (OAT1/3 probe) pharmacokinetics in 16 healthy volunteers. FDA table, May 29, 2026; Nguyen 2021 Supplements A–Z: Goldenseal |
| SLC22A8 OAT3Organic anion transporter 3UniProt Q8TCC7 | — | Organic anion/dicarboxylate exchanger (OAT3) that takes up anions such as estrone 3-sulfate and urate. | Basolateral cell membrane | Kidney and bladder Group enriched: kidney 313, choroid plexus 266 nTPM HPA UniProt: “Strongly expressed in kidney …” | Human study In FDA's transporter table (methotrexate: substrate). Goldenseal did not change furosemide (OAT1/3 probe) pharmacokinetics in 16 healthy volunteers. FDA table, May 29, 2026; Nguyen 2021 Supplements A–Z: Goldenseal |
| SLC5A2 SGLT2Sodium/glucose cotransporter 2UniProt P31639 | — | Sodium-coupled glucose symporter (1:1) that reabsorbs D-glucose from glomerular filtrate in the early proximal tubule. | Apical cell membrane | Kidney and bladder Tissue enriched: kidney 52 nTPM HPA | — |
| SLC47A2 MATE2-KMultidrug and toxin extrusion protein 2UniProt Q86VL8 | — | Proton/organic cation antiporter that effluxes cations such as tetraethylammonium, MPP+ and oxaliplatin. | Cell membrane; Apical cell membrane | Brain, spinal cord and retina Group enriched: choroid plexus 123, kidney 61 nTPM HPA UniProt: “High expression in kidney …” | FDA In FDA's transporter table (metformin: substrate of MATE1, MATE2-K and OCT2). FDA table, May 29, 2026 |
| SLCO1A2 OATP1A2Solute carrier organic anion transporter family member 1A2UniProt P46721 | — | Sodium-independent uptake of bile salts, hormones and clinically used drugs; acts at the blood–brain and blood–cerebrospinal fluid barriers. | Cell membrane; Basal cell membrane | Brain, spinal cord and retina Tissue enhanced: brain 15, salivary gland 15, liver 7.5, choroid plexus 7.0 nTPM HPA UniProt: “Higher expression in the brain than in liver and kidney …” | — |
| SLC22A4 OCTN1Solute carrier family 22 member 4UniProt Q9H015 | — | Transports zwitterions and organic cations; a sodium- and pH-dependent symporter of food-derived ergothioneine, absorbing it in the small intestine and renal tubules. | Apical cell membrane; Basal cell membrane; Mitochondrion membrane | Blood-forming and lymphoid tissue Tissue enhanced: bone marrow 20 nTPM HPA UniProt: “Widely expressed …” | — |
| SLC7A5 LAT1Large neutral amino acids transporter small subunit 1UniProt Q01650 | — | With SLC3A2, a sodium-independent transporter of large neutral amino acids; also takes up thyroid hormones. | Apical cell membrane; Cell membrane; Lysosome membrane | Blood-forming and lymphoid tissue Tissue enhanced: bone marrow 104, esophagus 96 nTPM HPA UniProt: “Detected in placenta, in the syncytiotrophoblast layer (at protein level) …” | — |
| ABCB1 P-gpATP-dependent translocase ABCB1UniProt P08183 | EC 7.6.2.2 +1 more | ATP-dependent efflux pump that translocates phospholipids and drugs across membranes; responsible for decreased drug accumulation in multidrug-resistant cells. | Cell membrane; Apical cell membrane; Cytoplasm | Endocrine glands Tissue enhanced: adrenal gland 96, intestine 67 nTPM HPA UniProt: “Expressed in small intestine …” | Human study St John's wort for 14 days raised duodenal P-gp expression 1.4-fold and lowered digoxin exposure 18% in 8 healthy men. Dürr 2000 Supplements A–Z: St. John's wort |
| ABCC3 MRP3ATP-binding cassette sub-family C member 3UniProt O15438 | EC 7.6.2.- EC 7.6.2.2 EC 7.6.2.3 | ATP-dependent transporter at basolateral membranes of hepatocytes and intestinal cells, exporting glucuronide, glutathione and sulfate conjugates. | Basolateral cell membrane; Basal cell membrane | Endocrine glands Tissue enhanced: adrenal gland 58, liver 49 nTPM HPA UniProt: “Mainly expressed in the liver …” | — |
| SLC47A1 MATE1Multidrug and toxin extrusion protein 1UniProt Q96FL8 | — | Proton/organic cation antiporter that excretes cationic metabolites, drugs and toxins into urine and bile. | Cell membrane; Apical cell membrane | Endocrine glands Tissue enhanced: adrenal gland 125, liver 97, kidney 94 nTPM HPA UniProt: “Widely expressed …” | FDA In FDA's transporter table (metformin: substrate of MATE1, MATE2-K and OCT2). FDA table, May 29, 2026 |
| SLC2A1 GLUT1Solute carrier family 2, facilitated glucose transporter member 1UniProt P11166 | — | Facilitative transporter for constitutive or basal glucose uptake, with broad aldose specificity. | Cell membrane; Melanosome; Photoreceptor inner segment | Reproductive tissue and placenta Tissue enhanced: placenta 93 nTPM HPA UniProt: “Detected in erythrocytes (at protein level) …” | — |
| SLC11A2 DMT1Natural resistance-associated macrophage protein 2UniProt P49281 | — | Proton-coupled symporter of divalent metal ions, including Fe²⁺, Cd²⁺ and Co²⁺. | Early endosome membrane; Apical cell membrane; Late endosome membrane; +6 more | Many tissues (low tissue specificity) Low tissue specificity; detected in all; highest duodenum 50 nTPM HPA UniProt: “Ubiquitously expressed …” | Supplements A–Z: Iron |
| SLC16A1 MCT1Monocarboxylate transporter 1UniProt P53985 | — | Bidirectional proton-coupled transporter of monocarboxylates such as lactate, pyruvate, acetate and ketone bodies. | Cell membrane; Basolateral cell membrane; Apical cell membrane | Many tissues (low tissue specificity) Low tissue specificity; detected in all; highest retina 64 nTPM HPA UniProt: “Widely expressed …” | — |
| SLC40A1 ferroportinFerroportinUniProt Q9NP59 | — | Exports Fe²⁺ from cells, moving iron out of intestinal, splenic and hepatic cells; key to systemic iron homeostasis. | Cell membrane; Basolateral cell membrane | Many tissues (low tissue specificity) Low tissue specificity; detected in all; highest spleen 347 nTPM HPA UniProt: “Detected in erythrocytes (at protein level) …” | Supplements A–Z: Iron |
Regulators of enzyme expression 4 proteins
| Protein | EC number | Function (UniProt, summarized) | Location in the cell (UniProt) | Main expression (HPA tissue RNA) | Why it matters here |
|---|---|---|---|---|---|
| NR1I2 PXRNuclear receptor subfamily 1 group I member 2UniProt O75469 | — | Nuclear receptor activated by steroids, rifampicin and some plant metabolites; with RXR it induces genes including CYP3A4 and ABCB1. | Nucleus; Cytoplasm | Liver and gallbladder Group enriched: liver 44, intestine 29 nTPM HPA UniProt: “Expressed in liver, colon and small intestine” | In vitro In vitro: hyperforin from St John's wort binds PXR (Ki 27 nM) and induces CYP3A4 in primary human hepatocytes. Moore 2000 (in vitro) Supplements A–Z: St. John's wort |
| NR1I3 CARNuclear receptor subfamily 1 group I member 3UniProt Q14994 | — | Nuclear receptor that transactivates the phenobarbital-responsive element of CYP2B6 and the CYP3A4 xenobiotic response element. | Nucleus; Cytoplasm; Cytoplasm, cytoskeleton | Liver and gallbladder Tissue enriched: liver 159 nTPM HPA UniProt: “Predominantly expressed in liver” | — |
| AHR AhRAryl hydrocarbon receptorUniProt P35869 | — | Ligand-activated transcription factor sensing environmental, dietary and microbial compounds; induces phase I and II enzyme genes such as CYP1A1. | Cytoplasm; Nucleus | Many tissues (low tissue specificity) Low tissue specificity; detected in all; highest urinary bladder 46 nTPM HPA UniProt: “Expressed in all tissues tested including blood, brain, heart, kidney, liver, lung, pancreas and skeletal muscle …” | — |
| NFE2L2 NRF2Nuclear factor erythroid 2-related factor 2UniProt Q16236 | — | Transcription factor that binds antioxidant response elements and induces cytoprotective genes, including phase 2 detoxifying enzymes. | Cytoplasm, cytosol; Nucleus | Many tissues (low tissue specificity) Low tissue specificity; detected in all; highest esophagus 232 nTPM HPA UniProt: “Widely expressed …” | — |
Liver-test enzymes 9 proteins
| Protein | EC number | Function (UniProt, summarized) | Location in the cell (UniProt) | Main expression (HPA tissue RNA) | Why it matters here |
|---|---|---|---|---|---|
| BCHE butyrylcholinesteraseCholinesteraseUniProt P06276 | EC 3.1.1.8 | Broad-specificity esterase that contributes to inactivating acetylcholine and can degrade organophosphate esters. | Secreted | Liver and gallbladder Tissue enriched: liver 490 nTPM HPA UniProt: “Detected in blood plasma (at protein level) …” | — |
| GPT ALT1Alanine aminotransferase 1UniProt P24298 | EC 2.6.1.2 | Pyridoxal enzyme catalyzing reversible transamination of alanine and 2-oxoglutarate to pyruvate and glutamate; important in gluconeogenesis and amino acid metabolism. | Cytoplasm | Liver and gallbladder Tissue enhanced: liver 183 nTPM HPA UniProt: “Liver, kidney, heart, and skeletal muscles …” | Primary source ALT is more liver-specific than AST. LiverTox's R ratio, (ALT/ULN) ÷ (ALP/ULN), classes liver injury: > 5 hepatocellular, < 2 cholestatic. StatPearls 2026; LiverTox RUCAM |
| ALPI intestinal ALPIntestinal-type alkaline phosphataseUniProt P09923 | EC 3.1.3.1 | Alkaline phosphatase that can hydrolyze various phosphate compounds. | Cell membrane | Esophagus, stomach and intestine Tissue enriched: intestine 133 nTPM HPA | — |
| GPT2 ALT2Alanine aminotransferase 2UniProt Q8TD30 | EC 2.6.1.2 | Catalyzes reversible transamination of alanine and 2-oxoglutarate to pyruvate and glutamate. | Not annotated | Pancreas Tissue enhanced: pancreas 252, tongue 172, skeletal muscle 165 nTPM HPA UniProt: “Expressed at high levels in muscle, adipose tissue, kidney and brain and at lower levels in the liver and breast” | — |
| GGT1 GGTGlutathione hydrolase 1 proenzymeUniProt P19440 | EC 3.4.19.13 +2 more | Cleaves the γ-glutamyl bond of extracellular glutathione and its conjugates, releasing glutamate and cysteinyl-glycine; supports cysteine and glutathione homeostasis. | Cell membrane | Kidney and bladder Tissue enhanced: kidney 150, liver 104 nTPM HPA UniProt: “Detected in fetal and adult kidney and liver, adult pancreas, stomach, intestine, placenta and lung …” | Primary source A concordant GGT rise makes a hepatic or biliary source of a raised ALP more likely; a normal GGT raises the possibility of a nonhepatic source such as bone. StatPearls 2026 |
| GOT1 AST, cytosolicAspartate aminotransferase, cytoplasmicUniProt P17174 | EC 2.6.1.1 EC 2.6.1.3 | Cytosolic aminotransferase forming L-glutamate from L-aspartate or L-cysteine; regulates brain glutamate; involved in hepatic glucose synthesis during development. | Cytoplasm | Muscle and heart Tissue enhanced: tongue 945, heart muscle 479, skeletal muscle 459 nTPM HPA | Primary source AST is present in skeletal muscle, myocardium, kidney, brain, leukocytes and erythrocytes, in cytosolic and mitochondrial forms. StatPearls 2026 |
| GOT2 AST, mitochondrialAspartate aminotransferase, mitochondrialUniProt P00505 | EC 2.6.1.1 EC 2.6.1.7 | Mitochondrial aminotransferase in the malate–aspartate shuttle, key to intracellular NAD(H) redox balance; also forms kynurenic acid. | Mitochondrion matrix; Cell membrane | Muscle and heart Group enriched: tongue 679, skeletal muscle 654, liver 300, heart muscle 298, +1 more nTPM HPA | Primary source AST is present in skeletal muscle, myocardium, kidney, brain, leukocytes and erythrocytes, in cytosolic and mitochondrial forms. StatPearls 2026 |
| ALPL tissue-nonspecific ALPAlkaline phosphatase, tissue-nonspecific isozymeUniProt P05186 | EC 3.1.3.1 +1 more | Alkaline phosphatase with broad substrate range; hydrolyzes pyrophosphate, pyridoxal 5′-phosphate and phosphocreatine and is key to bone and tooth mineralization. | Cell membrane; Extracellular vesicle membrane; Mitochondrion membrane; +1 more | Endocrine glands Tissue enhanced: adrenal gland 58 nTPM HPA | Primary source Serum ALP comes from liver, bone, placenta and intestine; ALP enters LiverTox's R ratio for drug-induced liver injury. StatPearls 2026; LiverTox RUCAM |
| ALPP placental ALPAlkaline phosphatase, placental typeUniProt P05187 | EC 3.1.3.1 | Alkaline phosphatase that can hydrolyze various phosphate compounds. | Cell membrane | Reproductive tissue and placenta Group enriched: placenta 33, cervix 17 nTPM HPA UniProt: “Detected in placenta (at protein level)” | — |
Neurotransmitter enzymes and transporters 18 proteins
| Protein | EC number | Function (UniProt, summarized) | Location in the cell (UniProt) | Main expression (HPA tissue RNA) | Why it matters here |
|---|---|---|---|---|---|
| SLC6A4 SERTSodium-dependent serotonin transporterUniProt P31645 | — | Serotonin transporter: moves serotonin into the cell with Na⁺ in exchange for K⁺, limiting its extracellular signaling. | Cell membrane; Endomembrane system; Endosome membrane; +3 more | Esophagus, stomach and intestine Group enriched: intestine 38, lung 27, placenta 17 nTPM HPA UniProt: “Expressed in platelets (at protein level)” | — |
| TPH1Tryptophan 5-hydroxylase 1UniProt P17752 | EC 1.14.16.4 | Oxidizes L-tryptophan to 5-hydroxy-L-tryptophan, the rate-determining step of serotonin synthesis. | Not annotated | Esophagus, stomach and intestine Group enriched: intestine 19, stomach 14, choroid plexus 6.4 nTPM HPA UniProt: “Seems to be less widely expressed than isoform 1” | — |
| DDC aromatic L-amino acid decarboxylaseAromatic-L-amino-acid decarboxylaseUniProt P20711 | EC 4.1.1.28 | Decarboxylates L-DOPA to dopamine and 5-hydroxytryptophan to serotonin. | Not annotated | Kidney and bladder Tissue enhanced: kidney 294, retina 163, intestine 156 nTPM HPA UniProt: “High expression in kidney” | — |
| AANATSerotonin N-acetyltransferaseUniProt Q16613 | EC 2.3.1.87 | N-acetylates serotonin to N-acetylserotonin, the penultimate step of melatonin synthesis; controls its night–day rhythm in the pineal gland. | Cytoplasm | Brain, spinal cord and retina Tissue enhanced: retina 10, testis 4.5 nTPM HPA UniProt: “Highly expressed in pineal gland and at lower levels in the retina …” | Supplements A–Z: Melatonin |
| ASMTAcetylserotonin O-methyltransferaseUniProt P46597 | EC 2.1.1.4 | Transfers a methyl group onto N-acetylserotonin, producing melatonin. | Not annotated | Brain, spinal cord and retina Tissue enriched: choroid plexus 7.2 nTPM HPA UniProt: “Expressed in the pineal gland (at protein level) …” | Supplements A–Z: Melatonin |
| GAD1 GAD67Glutamate decarboxylase 1UniProt Q99259 | EC 4.1.1.15 | Synthesizes the inhibitory neurotransmitter GABA from glutamate, with pyridoxal 5′-phosphate as cofactor. | Not annotated | Brain, spinal cord and retina Group enriched: brain 69, parathyroid gland 43, retina 28 nTPM HPA UniProt: “Expressed in brain” (and for UGT1A3: “Expressed in liver, kidney, colon, esophagus and small intestine”; for HMGCR: “Ubiquitously expressed with the highest levels in the cerebellum, fetal brain, testis, skin and adrenal gland”; for TPH1: remove the UniProt quote) | — |
| GAD2 GAD65Glutamate decarboxylase 2UniProt Q05329 | EC 4.1.1.15 | Catalyzes the production of GABA. | Cytoplasm, cytosol; Cytoplasmic vesicle; Presynaptic cell membrane; +1 more | Brain, spinal cord and retina Tissue enriched: brain 65 nTPM HPA | — |
| SLC18A2 VMAT2Synaptic vesicular amine transporterUniProt Q05940 | — | Vesicular antiporter exchanging one monoamine for two protons, concentrating monoamines in synaptic and secretory vesicles. | Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane; Cytoplasmic vesicle, secretory vesicle membrane; Cell projection, axon; +1 more | Brain, spinal cord and retina Tissue enhanced: brain 36, cervix 28 nTPM HPA UniProt: “Expressed in neuronal and neuroendocrine tissues …” | — |
| SLC6A3 DATSodium-dependent dopamine transporterUniProt Q01959 | — | Sodium- and chloride-dependent dopamine transporter; also transports noradrenaline. | Cell membrane; Cell projection, neuron projection; Cell projection, axon | Brain, spinal cord and retina Tissue enriched: brain 93 nTPM HPA UniProt: “Highly expressed in substantia nigra …” | — |
| ACHE AChEAcetylcholinesteraseUniProt P22303 | EC 3.1.1.7 | Rapidly hydrolyzes acetylcholine released into the synaptic cleft, ending signal transmission at the neuromuscular junction. | Synapse; Secreted; Cell membrane; +1 more | Muscle and heart Group enriched: skeletal muscle 153, brain 104, tongue 45 nTPM HPA UniProt: “Isoform H is highly expressed in erythrocytes” | — |
| DBHDopamine beta-hydroxylaseUniProt P09172 | EC 1.14.17.1 | Hydroxylates dopamine to noradrenaline. | Cytoplasmic vesicle, secretory vesicle lumen; Cytoplasmic vesicle, secretory vesicle, chromaffin granule lumen; Secreted; +2 more | Endocrine glands Tissue enriched: adrenal gland 257 nTPM HPA | — |
| PNMTPhenylethanolamine N-methyltransferaseUniProt P11086 | EC 2.1.1.28 | Methylates noradrenaline to adrenaline using S-adenosyl-L-methionine. | Not annotated | Endocrine glands Tissue enhanced: adrenal gland 149, brain 53 nTPM HPA | — |
| SLC6A2 NETSodium-dependent noradrenaline transporterUniProt P23975 | — | Sodium- and chloride-dependent noradrenaline transporter responsible for its reuptake and clearance. | Cell membrane; Cell projection, axon; Synapse, synaptosome | Endocrine glands Tissue enhanced: adrenal gland 9.9, placenta 6.4, skin 4.4, testis 4.2 nTPM HPA | — |
| TH tyrosine hydroxylaseTyrosine 3-monooxygenaseUniProt P07101 | EC 1.14.16.2 | Converts L-tyrosine to L-DOPA, the rate-limiting step of dopamine, noradrenaline and adrenaline synthesis, using tetrahydrobiopterin and oxygen. | Cytoplasm, perinuclear region; Nucleus; Cell projection, axon; +2 more | Endocrine glands Group enriched: adrenal gland 186, brain 130 nTPM HPA UniProt: “Mainly expressed in the brain and adrenal glands” | — |
| CHAT ChATCholine O-acetyltransferaseUniProt P28329 | EC 2.3.1.6 | Synthesizes acetylcholine from acetyl-CoA and choline at cholinergic synapses. | Not annotated | Reproductive tissue and placenta Group enriched: placenta 5.1, brain 3.7 nTPM HPA | — |
| FAAHFatty-acid amide hydrolase 1UniProt O00519 | EC 3.5.1.99 +1 more | Hydrolyzes amidated lipids such as anandamide and oleamide to fatty acids, regulating their signaling. | Endomembrane system; Cytoplasm, cytoskeleton | Many tissues (low tissue specificity) Low tissue specificity; detected in all; highest testis 46 nTPM HPA UniProt: “Highly expressed in the brain, small intestine, pancreas, skeletal muscle and testis …” | — |
| MGLL monoacylglycerol lipaseMonoglyceride lipaseUniProt Q99685 | EC 3.1.1.23 | Converts monoacylglycerides to fatty acids and glycerol; hydrolyzes the endocannabinoid 2-arachidonoylglycerol. | Cytoplasm, cytosol; Membrane | Many tissues (low tissue specificity) Low tissue specificity; detected in all; highest adipose tissue 161 nTPM HPA UniProt: “Detected in adipose tissue, lung, liver, kidney, brain and heart” | — |
| TPH2Tryptophan 5-hydroxylase 2UniProt Q8IWU9 | EC 1.14.16.4 | Neuron-specific enzyme converting L-tryptophan to 5-hydroxy-L-tryptophan, the rate-limiting step in serotonin production. | Not annotated | Not detected or not in HPA Not detected in HPA tissue RNA HPA UniProt: “Brain specific” | — |
Plasma proteins 16 proteins
| Protein | EC number | Function (UniProt, summarized) | Location in the cell (UniProt) | Main expression (HPA tissue RNA) | Why it matters here |
|---|---|---|---|---|---|
| ALB albuminAlbuminUniProt P02768 | — | Binds water, ions, fatty acids, hormones, bilirubin and drugs; main regulator of plasma colloid osmotic pressure; carries about 80% of plasma zinc. | Secreted | Liver and gallbladder Tissue enriched: liver 198,524 nTPM HPA UniProt: “Plasma” | — |
| APOA1Apolipoprotein A-IUniProt P02647 | — | Promotes cholesterol efflux from tissues for reverse transport to the liver and acts as cofactor for lecithin–cholesterol acyltransferase. | Secreted | Liver and gallbladder Tissue enriched: liver 20,151 nTPM HPA UniProt: “Major protein of plasma HDL, also found in chylomicrons …” | — |
| APOBApolipoprotein B-100UniProt P04114 | — | Major protein of chylomicrons (apoB-48), LDL and VLDL (apoB-100); apoB-100 is the recognition signal for cellular LDL uptake. | Cytoplasm; Secreted; Lipid droplet | Liver and gallbladder Group enriched: liver 1,114, intestine 287 nTPM HPA | — |
| CP ceruloplasminCeruloplasminUniProt P00450 | EC 1.16.3.4 +3 more | Copper-binding glycoprotein (6–7 Cu atoms) with ferroxidase activity, oxidizing Fe²⁺ to Fe³⁺; involved in iron transport across membranes. | Secreted | Liver and gallbladder Tissue enriched: liver 1,750 nTPM HPA UniProt: “Expressed by the liver and secreted in plasma” | Supplements A–Z: Copper |
| CRP C-reactive proteinC-reactive proteinUniProt P02741 | — | Host-defense protein that promotes agglutination, phagocytosis and complement fixation through calcium-dependent binding to phosphorylcholine. | Secreted | Liver and gallbladder Tissue enriched: liver 8,525 nTPM HPA UniProt: “Found in plasma” | — |
| FGA fibrinogen α chainFibrinogen alpha chainUniProt P02671 | — | Cleaved by thrombin; with fibrinogen β and γ chains polymerizes into the insoluble fibrin matrix of blood clots. | Secreted | Liver and gallbladder Tissue enriched: liver 17,202 nTPM HPA UniProt: “Detected in blood plasma (at protein level)” | — |
| GC vitamin D-binding proteinVitamin D-binding proteinUniProt P02774 | — | Involved in vitamin D transport and storage, scavenging extracellular G-actin and supporting neutrophil chemotaxis and macrophage activation. | Secreted | Liver and gallbladder Tissue enriched: liver 7,722 nTPM HPA UniProt: “Expressed in the liver …” | Supplements A–Z: Vitamin D |
| HP haptoglobinHaptoglobinUniProt P00738 | — | Captures free plasma hemoglobin after hemolysis, allowing hepatic recycling of heme iron and preventing kidney damage. | Secreted | Liver and gallbladder Tissue enriched: liver 55,848 nTPM HPA UniProt: “Expressed by the liver and secreted in plasma” | — |
| ORM1 α1-acid glycoprotein 1Alpha-1-acid glycoprotein 1UniProt P02763 | — | Blood transport protein that binds ligands, including synthetic drugs, and influences their distribution and availability; may modulate immunity in the acute phase. | Secreted | Liver and gallbladder Tissue enriched: liver 42,168 nTPM HPA UniProt: “Expressed by the liver and secreted in plasma” | — |
| RBP4 retinol-binding protein 4Retinol-binding protein 4UniProt P02753 | — | Transports retinol in blood plasma from liver stores to peripheral tissues and transfers it to STRA6 for transport across the cell membrane. | Secreted | Liver and gallbladder Tissue enriched: liver 11,054 nTPM HPA UniProt: “Detected in blood plasma and in urine (at protein level)” | Supplements A–Z: Vitamin A |
| SELENOP selenoprotein PSelenoprotein PUniProt P49908 | — | Might provide extracellular antioxidant defense or transport selenium; may supply selenium to tissues such as brain and testis. | Secreted | Liver and gallbladder Group enriched: liver 5,860, intestine 1,966 nTPM HPA UniProt: “Made in the liver and heart and secreted into the plasma …” | Primary source NIH ODS: selenoprotein P and glutathione peroxidase 3 are the predominant plasma selenoproteins and can serve as functional status biomarkers. NIH ODS selenium Supplements A–Z: Selenium |
| SERPINA1 α1-antitrypsinAlpha-1-antitrypsinUniProt P01009 | — | Serine protease inhibitor whose primary target is elastase; also inhibits plasmin, thrombin, trypsin and chymotrypsin. | Secreted; Endoplasmic reticulum; Secreted, extracellular space, extracellular matrix | Liver and gallbladder Tissue enriched: liver 31,417 nTPM HPA UniProt: “Ubiquitous …” | — |
| SHBGSex hormone-binding globulinUniProt P04278 | — | Transports androgens and estradiol in plasma, binding one steroid per dimer, and regulates their plasma metabolic clearance. | Secreted | Liver and gallbladder Tissue enriched: liver 59 nTPM HPA UniProt: “Isoform 1 and isoform 2 are present in liver and testis” | — |
| TF transferrinSerotransferrinUniProt P02787 | — | Binds two Fe³⁺ ions and transports iron from absorption and heme-degradation sites to storage and use. | Secreted | Liver and gallbladder Group enriched: liver 7,020, retina 2,257 nTPM HPA UniProt: “Expressed by the liver and secreted in plasma” | Primary source NIH ODS: in the second stage of iron deficiency, plasma iron falls and plasma transferrin (measured as total iron-binding capacity) rises, lowering transferrin saturation. NIH ODS iron Supplements A–Z: Iron |
| TCN2 transcobalaminTranscobalamin-2UniProt P20062 | — | Primary vitamin B12-binding and transport protein; delivers cobalamin to cells. | Secreted | Kidney and bladder Tissue enhanced: kidney 108 nTPM HPA | Supplements A–Z: Vitamin B12 |
| TTR transthyretinTransthyretinUniProt P02766 | — | Thyroid hormone-binding protein that probably transports thyroxine from the bloodstream to the brain. | Secreted; Cytoplasm | Brain, spinal cord and retina Tissue enriched: choroid plexus 672,504 nTPM HPA UniProt: “Detected in serum and cerebrospinal fluid (at protein level) …” | — |
Antioxidant and metabolic enzymes 18 proteins
| Protein | EC number | Function (UniProt, summarized) | Location in the cell (UniProt) | Main expression (HPA tissue RNA) | Why it matters here |
|---|---|---|---|---|---|
| CAT catalaseCatalaseUniProt P04040 | EC 1.11.1.6 | Degrades hydrogen peroxide generated by peroxisomal oxidases to water and oxygen, protecting cells from its toxic effects. | Peroxisome matrix | Liver and gallbladder Tissue enhanced: liver 1,138 nTPM HPA | — |
| GCLCGlutamate--cysteine ligase catalytic subunitUniProt P48506 | EC 6.3.2.2 | Catalyzes ATP-dependent ligation of glutamate and cysteine, the first and rate-limiting step of glutathione synthesis. | Not annotated | Liver and gallbladder Tissue enhanced: liver 142 nTPM HPA | — |
| HMGCR HMG-CoA reductase3-hydroxy-3-methylglutaryl-coenzyme A reductaseUniProt P04035 | EC 1.1.1.34 | Converts HMG-CoA to mevalonic acid, the rate-limiting step of cholesterol and isoprenoid synthesis; the main target of statins. | Endoplasmic reticulum membrane; Peroxisome membrane | Liver and gallbladder Tissue enhanced: liver 99 nTPM HPA UniProt: “Ubiquitously expressed with the highest levels in the cerebellum, fetal brain, testis, skin and adrenal gland Detected in the cerebellum, fetal brain, testis and …” | Primary source NCCIH: monacolin K in red yeast rice is structurally identical to lovastatin, a statin. NCCIH |
| SOD1 Cu/Zn SODSuperoxide dismutase [Cu-Zn]UniProt P00441 | EC 1.15.1.1 EC 1.8.-.- | Copper–zinc superoxide dismutase that destroys radicals produced within cells; also oxidizes hydrogen sulfide to sulfate. | Cytoplasm; Nucleus | Liver and gallbladder Tissue enhanced: liver 1,537 nTPM HPA | Supplements A–Z: Copper, Zinc |
| NQO1NAD(P)H dehydrogenase [quinone] 1UniProt P15559 | EC 1.6.5.2 | Flavin quinone reductase that reduces quinones to hydroquinones by two electrons, using NADH or NADPH. | Cytoplasm, cytosol | Esophagus, stomach and intestine Tissue enhanced: stomach 493 nTPM HPA | — |
| GATM AGATGlycine amidinotransferase, mitochondrialUniProt P50440 | EC 2.1.4.1 | Transfers the amidino group of L-arginine to glycine and other acceptors, forming guanidinoacetate and related guanidines. | Mitochondrion inner membrane; Cytoplasm | Pancreas Group enriched: pancreas 2,768, liver 2,621, kidney 1,960 nTPM HPA UniProt: “Expressed in brain, heart, kidney, liver, lung, salivary gland and skeletal muscle tissue, with the highest expression in kidney …” | Supplements A–Z: Creatine |
| CD38ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1UniProt P28907 | EC 3.2.2.- EC 3.2.2.6 +1 more | Transmembrane glycoprotein that synthesizes and hydrolyzes cyclic ADP-ribose, makes NAADP⁺, mobilizes calcium and acts as a lymphocyte receptor. | Cell surface; Cell membrane | Blood-forming and lymphoid tissue Tissue enhanced: lymphoid tissue 59 nTPM HPA UniProt: “Expressed at high levels in pancreas, liver, kidney, brain, testis, ovary, placenta, malignant lymphoma and neuroblastoma” | — |
| HMOX1 heme oxygenase 1Heme oxygenase 1UniProt P09601 | EC 1.14.14.18 | Cleaves heme to biliverdin IXα, carbon monoxide and ferrous iron. | Endoplasmic reticulum membrane | Blood-forming and lymphoid tissue Tissue enriched: lymphoid tissue 740 nTPM HPA UniProt: “Expressed at higher levels in renal cancer tissue than in normal tissue (at protein level)” | — |
| NAMPTNicotinamide phosphoribosyltransferaseUniProt P43490 | EC 2.4.2.12 | Condenses nicotinamide with PRPP to nicotinamide mononucleotide; the rate-limiting step of mammalian NAD biosynthesis. | Nucleus; Cytoplasm; Secreted | Blood-forming and lymphoid tissue Tissue enhanced: lymphoid tissue 339 nTPM HPA UniProt: “Expressed in large amounts in bone marrow, liver tissue, and muscle …” | Supplements A–Z: NMN (nicotinamide mononucleotide) |
| SOD2 Mn SODSuperoxide dismutase [Mn], mitochondrialUniProt P04179 | EC 1.15.1.1 | Mitochondrial manganese superoxide dismutase that destroys superoxide anion radicals. | Mitochondrion matrix | Blood-forming and lymphoid tissue Tissue enhanced: bone marrow 1,022 nTPM HPA | — |
| CKM muscle creatine kinaseCreatine kinase M-typeUniProt P06732 | EC 2.7.3.2 | Reversibly transfers phosphate between ATP and phosphagens such as creatine phosphate; central to energy transduction in muscle, heart and brain. | Cytoplasm | Muscle and heart Group enriched: skeletal muscle 68,909, tongue 24,326 nTPM HPA | Supplements A–Z: Creatine |
| GAMTGuanidinoacetate N-methyltransferaseUniProt Q14353 | EC 2.1.1.2 | Converts guanidinoacetate to creatine using S-adenosylmethionine as methyl donor. | Not annotated | Muscle and heart Tissue enhanced: skeletal muscle 1,157, liver 610, tongue 435 nTPM HPA UniProt: “Expressed in liver” | Supplements A–Z: Creatine |
| CPT1ACarnitine O-palmitoyltransferase 1, liver isoformUniProt P50416 | EC 2.3.1.21 +1 more | Transfers long-chain acyl groups from acyl-CoA to carnitine, essential for mitochondrial uptake and β-oxidation of long-chain fatty acids. | Mitochondrion outer membrane | Many tissues (low tissue specificity) Low tissue specificity; detected in all; highest small intestine 67 nTPM HPA UniProt: “Strong expression in kidney and heart, and lower in liver and skeletal muscle” | Supplements A–Z: L-carnitine |
| GPX1Glutathione peroxidase 1UniProt P07203 | EC 1.11.1.9 +1 more | Reduces hydroperoxides, such as H₂O₂ and fatty acid hydroperoxides, using glutathione; regulates cellular redox homeostasis. | Cytoplasm; Mitochondrion | Many tissues (low tissue specificity) Low tissue specificity; detected in all; highest liver 622 nTPM HPA UniProt: “Expressed in platelets (at protein level)” | Primary source NIH ODS: selenium is a constituent of 25 selenoproteins, including glutathione peroxidases and thioredoxin reductases. NIH ODS selenium Supplements A–Z: Selenium |
| MTOR mTORSerine/threonine-protein kinase mTORUniProt P42345 | EC 2.7.11.1 +1 more | Serine/threonine kinase in mTORC1 and mTORC2 that regulates metabolism, growth and survival in response to nutrients, hormones, energy and stress. | Lysosome membrane; Endoplasmic reticulum membrane; Golgi apparatus membrane; +7 more | Many tissues (low tissue specificity) Low tissue specificity; detected in all; highest testis 20 nTPM HPA UniProt: “Expressed in numerous tissues, with highest levels in testis” | — |
| PRKAA1 AMPK α15'-AMP-activated protein kinase catalytic subunit alpha-1UniProt Q13131 | EC 2.7.11.1 +2 more | Catalytic subunit of AMPK, the energy sensor that activates energy-producing and inhibits energy-consuming pathways when cellular ATP falls. | Cytoplasm; Nucleus; Late endosome | Many tissues (low tissue specificity) Low tissue specificity; detected in all; highest bone marrow 49 nTPM HPA | — |
| SIRT1NAD-dependent protein deacetylase sirtuin-1UniProt Q96EB6 | EC 2.3.1.286 +1 more | NAD-dependent protein deacetylase linking transcription to cellular energetics; senses the NAD⁺/NADH ratio and regulates many transcription factors. | Nucleus, PML body; Cytoplasm; Nucleus; +2 more | Many tissues (low tissue specificity) Low tissue specificity; detected in all; highest adrenal gland 28 nTPM HPA UniProt: “Widely expressed” | — |
| TXNRD1 thioredoxin reductase 1Thioredoxin reductase 1, cytoplasmicUniProt Q16881 | EC 1.8.1.9 +1 more | Selenocysteine-containing flavoprotein that reduces thioredoxin; the C-terminal selenocysteine is essential for catalysis. | Cytoplasm; Nucleus | Many tissues (low tissue specificity) Low tissue specificity; detected in all; highest adrenal gland 138 nTPM HPA UniProt: “Expressed predominantly in Leydig cells (at protein level) …” | Primary source NIH ODS: selenium is a constituent of 25 selenoproteins, including glutathione peroxidases and thioredoxin reductases. NIH ODS selenium Supplements A–Z: Selenium |
Vitamin-related enzymes and carriers 15 proteins
| Protein | EC number | Function (UniProt, summarized) | Location in the cell (UniProt) | Main expression (HPA tissue RNA) | Why it matters here |
|---|---|---|---|---|---|
| CYP4F2Cytochrome P450 4F2UniProt P78329 | EC 1.14.14.1 +3 more | Omega-hydroxylates fatty acids and eicosanoids; inactivates phylloquinone and menaquinone-4 and hydroxylates tocopherols, preferring γ- over α-tocopherol. | Microsome membrane; Endoplasmic reticulum membrane | Liver and gallbladder Tissue enhanced: liver 156, intestine 76, kidney 38 nTPM HPA UniProt: “Liver …” | Supplements A–Z: Vitamin K, Vitamin E |
| GGCX γ-glutamyl carboxylaseVitamin K-dependent gamma-carboxylaseUniProt P38435 | EC 4.1.1.90 | Carboxylates glutamate residues to calcium-binding Gla residues, epoxidizing vitamin K hydroquinone to vitamin K epoxide. | Endoplasmic reticulum membrane | Liver and gallbladder Tissue enriched: liver 101 nTPM HPA | Primary source NIH ODS: vitamin K is a coenzyme for vitamin K-dependent carboxylase; warfarin antagonizes vitamin K, so users need consistent vitamin K intake. NIH ODS vitamin K Supplements A–Z: Vitamin K |
| LRATLecithin retinol acyltransferaseUniProt O95237 | EC 2.3.1.135 | Transfers an acyl group from phosphatidylcholine to all-trans-retinol, forming retinyl esters, the storage form of vitamin A. | Endoplasmic reticulum membrane; Rough endoplasmic reticulum; Endosome, multivesicular body; +1 more | Liver and gallbladder Tissue enhanced: liver 2.0, brain 1.9 nTPM HPA UniProt: “Hepatic stellate cells and endothelial cells (at protein level) …” | Primary source NIH ODS: most of the body's vitamin A is stored in the liver as retinyl esters. NIH ODS vitamin A Supplements A–Z: Vitamin A |
| MMUT methylmalonyl-CoA mutaseMethylmalonyl-CoA mutase, mitochondrialUniProt P22033 | EC 5.4.99.2 | Isomerizes methylmalonyl-CoA from branched-chain amino acid and odd-chain fatty acid breakdown to succinyl-CoA. | Mitochondrion matrix; Mitochondrion; Cytoplasm | Liver and gallbladder Tissue enhanced: liver 186 nTPM HPA | Primary source NIH ODS: vitamin B12 is a cofactor for L-methylmalonyl-CoA mutase; serum methylmalonic acid is the most sensitive marker of B12 status. NIH ODS vitamin B12 Supplements A–Z: Vitamin B12 |
| TTPA α-tocopherol transfer proteinAlpha-tocopherol transfer proteinUniProt P49638 | — | Binds α-tocopherol, enhances its transfer between membranes and stimulates its release from liver cells. | Cytoplasm | Liver and gallbladder Tissue enriched: liver 154 nTPM HPA | Primary source NIH ODS: the liver preferentially resecretes α-tocopherol via this protein and metabolizes the other vitamin E forms. NIH ODS vitamin E Supplements A–Z: Vitamin E |
| VKORC1Vitamin K epoxide reductase complex subunit 1UniProt Q9BQB6 | EC 1.17.4.4 | Catalytic subunit of vitamin K epoxide reductase, which reduces vitamin K 2,3-epoxide back to active vitamin K needed for γ-carboxylation. | Endoplasmic reticulum membrane | Liver and gallbladder Tissue enhanced: liver 526 nTPM HPA UniProt: “Expressed at highest levels in fetal and adult liver, followed by fetal heart, kidney, and lung, adult heart, and pancreas” | Primary source NIH ODS: warfarin antagonizes vitamin K activity, so people taking it need consistent vitamin K intakes. NIH ODS vitamin K Supplements A–Z: Vitamin K |
| BCO1Beta,beta-carotene 15,15'-dioxygenaseUniProt Q9HAY6 | EC 1.13.11.63 | Symmetrically cleaves β-carotene into two molecules of retinal. | Cytoplasm, cytosol | Esophagus, stomach and intestine Tissue enhanced: intestine 14, choroid plexus 12 nTPM HPA UniProt: “Highly expressed in retinal pigment epithelium …” | Primary source NIH ODS: the body converts provitamin A carotenoids into vitamin A in the intestine via beta-carotene monooxygenase type 1 (BCMO1); the rate may vary between people genetically. NIH ODS vitamin A Supplements A–Z: Vitamin A |
| TPK1 thiamine pyrophosphokinaseThiamine pyrophosphokinase 1UniProt Q9H3S4 | EC 2.7.6.- | Phosphorylates thiamine to thiamine pyrophosphate, a cofactor of mitochondrial pyruvate dehydrogenase. | Not annotated | Esophagus, stomach and intestine Tissue enhanced: intestine 13 nTPM HPA UniProt: “Detected in heart, kidney, testis, small intestine and peripheral blood leukocytes, and at very low levels in a variety of tissues” | Supplements A–Z: Thiamin (vitamin B1) |
| CYP24A11,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrialUniProt Q07973 | EC 1.14.15.16 | Inactivates both calcidiol and calcitriol by C24- and C23-oxidation; key in vitamin D catabolism and calcium homeostasis. | Mitochondrion | Kidney and bladder Group enriched: kidney 32, urinary bladder 27, endometrium 14, lymphoid tissue 9.9, +1 more nTPM HPA | Supplements A–Z: Vitamin D |
| CYP27B125-hydroxyvitamin D-1 alpha hydroxylase, mitochondrialUniProt O15528 | EC 1.14.15.18 | Hydroxylates 25-hydroxyvitamin D₃ at C-1α in the kidney, the rate-limiting step forming hormonally active calcitriol. | Mitochondrion membrane | Kidney and bladder Tissue enhanced: kidney 19, thyroid gland 5.3 nTPM HPA UniProt: “Kidney” | Primary source NIH ODS: the second hydroxylation, mainly in the kidney, forms the physiologically active calcitriol. NIH ODS vitamin D Supplements A–Z: Vitamin D |
| PDXK pyridoxal kinasePyridoxal kinaseUniProt O00764 | EC 2.7.1.35 | Phosphorylates the dietary vitamin B6 forms pyridoxal, pyridoxine and pyridoxamine to their 5′-phosphates, including pyridoxal 5′-phosphate (PLP). | Cytoplasm, cytosol | Brain, spinal cord and retina Tissue enhanced: brain 73 nTPM HPA UniProt: “Ubiquitous …” | Supplements A–Z: Vitamin B6 |
| CYP2R1Vitamin D 25-hydroxylaseUniProt Q6VVX0 | EC 1.14.14.24 | Vitamin D 25-hydroxylase: hydroxylates vitamin D₂ and D₃ at C-25 to activate vitamin D precursors. | Endoplasmic reticulum membrane; Microsome membrane | Many tissues (low tissue specificity) Low tissue specificity; detected in many; highest skin 6.6 nTPM HPA | Primary source NIH ODS: the first, hepatic hydroxylation gives 25-hydroxyvitamin D, whose serum level is the main indicator of vitamin D status. NIH ODS vitamin D Supplements A–Z: Vitamin D |
| DHFRDihydrofolate reductaseUniProt P00374 | EC 1.5.1.3 | Reduces 7,8-dihydrofolate to 5,6,7,8-tetrahydrofolate using NADPH; a key enzyme in folate metabolism. | Mitochondrion; Cytoplasm; Nucleus | Many tissues (low tissue specificity) Low tissue specificity; detected in all; highest thymus 56 nTPM HPA UniProt: “Widely expressed in fetal and adult tissues, including throughout the fetal and adult brains and whole blood …” | Primary source NIH ODS: before absorbed folate enters the bloodstream, dihydrofolate reductase reduces its monoglutamate form to THF; when its capacity is exceeded, unmetabolized folic acid can be present in blood. NIH ODS folate Supplements A–Z: Folate (folic acid) |
| MTHFRMethylenetetrahydrofolate reductase (NADPH)UniProt P42898 | EC 1.5.1.53 | Converts 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, the cosubstrate for remethylating homocysteine to methionine. | Not annotated | Many tissues (low tissue specificity) Low tissue specificity; detected in all; highest epididymis 50 nTPM HPA | Primary source NIH ODS: the MTHFR 677C>T polymorphism lowers available 5-MTHF; evidence on folate supplementation for carriers is inconclusive. NIH ODS folate Supplements A–Z: Folate (folic acid) |
| MTR methionine synthaseMethionine synthaseUniProt Q99707 | EC 2.1.1.13 | Transfers a methyl group from methylcobalamin to homocysteine, forming methionine; methylcobalamin is an active form of vitamin B12. | Cytoplasm | Many tissues (low tissue specificity) Low tissue specificity; detected in all; highest parathyroid gland 19 nTPM HPA UniProt: “Widely expressed …” | Primary source NIH ODS: vitamin B12 is a cofactor for methionine synthase, which converts homocysteine to methionine. NIH ODS vitamin B12 Supplements A–Z: Vitamin B12, Folate (folic acid) |
UniProtKB/Swiss-Prot release 2026_03 and Human Protein Atlas 25.1, retrieved October 29, 2026. Notes: U.S. FDA interaction table (May 29, 2026); Mueller et al. 2006; Dürr et al. 2000; Moore et al. 2000 (in vitro); Nguyen et al. 2021; StatPearls; LiverTox; NCCIH; NIH Office of Dietary Supplements fact sheets. Full references on the sources page.
How the atlas was built, and what tissue RNA cannot show
Each accession was found with the UniProt query “gene_exact:<symbol> AND organism_id:9606 AND reviewed:true”, then checked: reviewed entry, human, primary gene name equal to the symbol. The recommended name, EC numbers, subcellular location, tissue specificity and FUNCTION text were taken from that record, and HPA tissue RNA from the HPA download API, on October 29, 2026.
Tissue RNA comes from a limited set of donors and tissue samples. It does not show differences between individuals, and it does not show induction or inhibition by a drug or supplement. Where a UniProt record has TISSUE SPECIFICITY text, the atlas quotes its first sentence.
The data are refreshed by re-running the retrieval script; records can change between UniProt and HPA releases.
UniProt REST API (rest.uniprot.org); Human Protein Atlas search_download API; both accessed October 29, 2026.
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.